These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. [Hypertrophy of the heart from the viewpont of pathologic anatomy]. Urbanová D Cesk Fysiol; 1978 Sep; 27(5):409-12. PubMed ID: 153204 [No Abstract] [Full Text] [Related]
27. [Morphology of cardiac enlargement (author's transl)]. Okada R Kokyu To Junkan; 1976 Jun; 24(6):481-9. PubMed ID: 136035 [No Abstract] [Full Text] [Related]
28. [Mosaic nature of pathological changes in the hypertrophic myocardium]. Vaĭl' SS Klin Med (Mosk); 1978 Jan; 56(1):24-8. PubMed ID: 147364 [No Abstract] [Full Text] [Related]
30. Ventricular weight in cardiac hypertrophy. FULTON RM; HUTCHINSON EC; JONES AM Br Heart J; 1952 Jul; 14(3):413-20. PubMed ID: 14944734 [No Abstract] [Full Text] [Related]
31. The role of TWEAK/Fn14 in cardiac remodeling. Ren MY; Sui SJ Mol Biol Rep; 2012 Nov; 39(11):9971-7. PubMed ID: 22752727 [TBL] [Abstract][Full Text] [Related]
32. Molecular and cellular mechanisms of cardiotoxicity. Kang YJ Environ Health Perspect; 2001 Mar; 109 Suppl 1(Suppl 1):27-34. PubMed ID: 11250803 [TBL] [Abstract][Full Text] [Related]
33. Myocardial imaging with 123I-BMIPP in patients with congestive heart failure. Ishida Y; Yasumura Y; Nagaya N; Fukuchi K; Komamura K; Takamiya M; Miyatake K Int J Card Imaging; 1999 Feb; 15(1):71-7. PubMed ID: 10453405 [TBL] [Abstract][Full Text] [Related]
34. Increased gene expression of plasminogen activators and inhibitors in left ventricular hypertrophy. Bloor CM; Nimmo L; McKirnan MD; Zhang Y; White FC Mol Cell Biochem; 1997 Nov; 176(1-2):265-71. PubMed ID: 9406171 [TBL] [Abstract][Full Text] [Related]
35. Ultrastructural changes in the canine myocardium with right ventricular hypertrophy and congestive heart failure. Bishop SP; Cole CR Lab Invest; 1969 Mar; 20(3):219-29. PubMed ID: 4237549 [No Abstract] [Full Text] [Related]
36. Myocardial hypertrophy in transgenic mice overexpressing human interleukin 1alpha. Isoda K; Kamezawa Y; Tada N; Sato M; Ohsuzu F J Card Fail; 2001 Dec; 7(4):355-64. PubMed ID: 11782860 [TBL] [Abstract][Full Text] [Related]
37. Disruption of leptin signaling contributes to cardiac hypertrophy independently of body weight in mice. Barouch LA; Berkowitz DE; Harrison RW; O'Donnell CP; Hare JM Circulation; 2003 Aug; 108(6):754-9. PubMed ID: 12885755 [TBL] [Abstract][Full Text] [Related]
38. Divergent roles of endothelial nitric oxide synthase in cardiac hypertrophy and chamber dilatation? Shah AM Cardiovasc Res; 2005 Jun; 66(3):421-2. PubMed ID: 15914104 [No Abstract] [Full Text] [Related]